{
    "id": "nclex_ngn_mm_2026_001",
    "questionType": "matrixMatch",
    "stem": "A 72-year-old male with a history of Bipolar I Disorder is brought to the emergency department by his daughter for evaluation of new-onset confusion and unsteadiness. The nurse is reviewing the client's electronic health record (EHR) and preparing a plan of care.",
    "prompt": "For each potential nursing action, click to specify if the action is Indicated (safe and appropriate) or Contraindicated (unsafe or not a priority) based on the client's data.",
    "tabs": [
        {
            "title": "Nurses' Notes",
            "content": "Client arrived via wheelchair, accompanied by daughter. Client is disoriented to time and place, speech is slurred. Daughter states, 'He's been getting more confused and shaky for the past two days. He can barely walk without falling.' Reports client ran out of his prescribed 'water pill' (furosemide) a week ago and started taking an 'herbal diuretic' he purchased online to 'save money.' Client exhibits coarse, bilateral hand tremors at rest. Ataxia noted upon attempt to stand. Skin turgor is poor, mucous membranes are dry."
        },
        {
            "title": "Vital Signs",
            "content": [
                {
                    "label": "Time",
                    "values": [
                        "14:00 (Arrival)",
                        "14:30"
                    ]
                },
                {
                    "label": "Temperature",
                    "values": [
                        "37.6째C (99.7째F)",
                        "37.7째C (99.9째F)"
                    ]
                },
                {
                    "label": "Heart Rate",
                    "values": [
                        "112 bpm",
                        "118 bpm"
                    ]
                },
                {
                    "label": "Blood Pressure",
                    "values": [
                        "94/58 mmHg",
                        "90/52 mmHg"
                    ]
                },
                {
                    "label": "Respiratory Rate",
                    "values": [
                        "18/min",
                        "20/min"
                    ]
                },
                {
                    "label": "SpO2",
                    "values": [
                        "97% on room air",
                        "96% on room air"
                    ]
                }
            ]
        },
        {
            "title": "Laboratory Results",
            "content": [
                {
                    "label": "Lithium",
                    "value": "2.2 mEq/L",
                    "range": "0.6-1.2 mEq/L"
                },
                {
                    "label": "Sodium (Na+)",
                    "value": "128 mEq/L",
                    "range": "136-145 mEq/L"
                },
                {
                    "label": "Potassium (K+)",
                    "value": "3.6 mEq/L",
                    "range": "3.5-5.0 mEq/L"
                },
                {
                    "label": "BUN",
                    "value": "35 mg/dL",
                    "range": "10-20 mg/dL"
                },
                {
                    "label": "Creatinine",
                    "value": "1.8 mg/dL",
                    "range": "0.6-1.2 mg/dL"
                }
            ]
        },
        {
            "title": "Diagnostic Results",
            "content": "12-Lead ECG Interpretation: Sinus tachycardia. Rate 115. Flattened T-waves and prominent U waves noted. QTc interval is borderline prolonged. No acute ST changes."
        },
        {
            "title": "Medication Administration Record (MAR)",
            "content": [
                {
                    "medication": "Lithium Carbonate 300 mg PO",
                    "route": "PO",
                    "frequency": "BID",
                    "due": "18:00"
                },
                {
                    "medication": "Furosemide 20 mg PO",
                    "route": "PO",
                    "frequency": "Daily",
                    "due": "09:00 (Not given today)"
                },
                {
                    "medication": "Lisinopril 10 mg PO",
                    "route": "PO",
                    "frequency": "Daily",
                    "due": "09:00 (Not given today)"
                }
            ]
        }
    ],
    "rows": [
        {
            "id": "row1",
            "label": "Administer scheduled Lithium Carbonate 300 mg PO."
        },
        {
            "id": "row2",
            "label": "Initiate seizure precautions."
        },
        {
            "id": "row3",
            "label": "Prepare for administration of an IV fluid bolus of 0.9% sodium chloride."
        },
        {
            "id": "row4",
            "label": "Administer the client's home medication Furosemide 20 mg PO."
        },
        {
            "id": "row5",
            "label": "Place the client on continuous cardiac monitoring."
        },
        {
            "id": "row6",
            "label": "Contact the provider to advocate for emergent hemodialysis."
        }
    ],
    "columns": [
        {
            "id": "col1",
            "label": "Indicated"
        },
        {
            "id": "col2",
            "label": "Contraindicated"
        }
    ],
    "correctResponse": {
        "row1": "col2",
        "row2": "col1",
        "row3": "col1",
        "row4": "col2",
        "row5": "col1",
        "row6": "col1"
    },
    "rationale": {
        "correct": "The comprehensive clinical picture indicates severe lithium toxicity (level 2.2 mEq/L) with significant neurological (confusion, ataxia, tremors), renal (elevated BUN/Cr), and cardiovascular (hypotension, tachycardia, ECG changes) manifestations. The toxicity was likely precipitated by dehydration and sodium depletion from the use of an unregulated herbal diuretic. The nurse's primary responsibility is to prevent further harm and initiate life-saving interventions. This involves immediately withholding any further doses of lithium, protecting the client from injury (seizure precautions), initiating measures to enhance lithium excretion (IV normal saline), monitoring for life-threatening complications (cardiac monitoring), and escalating care by advocating for the definitive treatment for severe toxicity (hemodialysis).",
        "incorrect": "Administering more lithium or another diuretic (furosemide) would be catastrophic, directly worsening the toxicity and leading to potential coma, seizures, or cardiovascular collapse. These actions represent a critical failure to recognize a life-threatening contraindication and constitute a 'DON'T PROCEED' safety stop moment in clinical practice.",
        "answerBreakdown": [
            {
                "label": "Administer scheduled Lithium Carbonate 300 mg PO.",
                "isCorrect": false,
                "rationale": "Contraindicated. This is the most critical 'SAFETY STOP' action. The client's lithium level is 2.2 mEq/L, which is in the severe toxicity range. Administering more lithium would dangerously increase the toxic load, worsening neurotoxicity and potentially leading to seizures, coma, or death."
            },
            {
                "label": "Initiate seizure precautions.",
                "isCorrect": true,
                "rationale": "Indicated. Severe lithium toxicity causes significant central nervous system irritability. The client's confusion, ataxia, and coarse tremors are signs of neurotoxicity, which can progress to seizures. Seizure precautions (e.g., padded side rails, suction at bedside) are a crucial safety measure."
            },
            {
                "label": "Prepare for administration of an IV fluid bolus of 0.9% sodium chloride.",
                "isCorrect": true,
                "rationale": "Indicated. Lithium is cleared renally and its excretion is directly related to sodium and hydration status. The client is dehydrated (poor turgor, tachycardia, hypotension) and hyponatremic (128 mEq/L). Administering isotonic saline (0.9% NaCl) will restore volume, increase glomerular filtration rate, and provide sodium to promote renal excretion of lithium."
            },
            {
                "label": "Administer the client's home medication Furosemide 20 mg PO.",
                "isCorrect": false,
                "rationale": "Contraindicated. Loop diuretics like furosemide cause sodium and water excretion. In this context, it would worsen the client's hyponatremia and dehydration, which would further decrease renal clearance of lithium and exacerbate the toxicity. This is another critical 'DON'T PROCEED' action."
            },
            {
                "label": "Place the client on continuous cardiac monitoring.",
                "isCorrect": true,
                "rationale": "Indicated. Lithium toxicity can cause cardiotoxicity, including dysrhythmias, bradycardia, and ECG changes like T-wave flattening and QTc prolongation, which are present in this client. Continuous cardiac monitoring is essential to detect and manage potentially lethal arrhythmias."
            },
            {
                "label": "Contact the provider to advocate for emergent hemodialysis.",
                "isCorrect": true,
                "rationale": "Indicated. For severe lithium toxicity (levels typically >2.5 mEq/L, or >2.0 mEq/L with severe symptoms like altered mental status, seizures, or renal failure), hemodialysis is the definitive and most effective treatment to rapidly remove lithium from the body. The nurse must recognize the severity and anticipate/advocate for this intervention."
            }
        ]
    },
    "pedagogy": {
        "bloomLevel": "Evaluate",
        "cjmmStep": "Take Actions",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "nclexSubcategory": "Adverse Effects/Contraindications/Side Effects/Toxicity",
        "difficulty": 4.5,
        "topicTags": [
            "Lithium Toxicity",
            "Medication Safety",
            "Contraindication",
            "Bipolar Disorder",
            "Fluid and Electrolytes",
            "Renal Failure",
            "Health Equity",
            "SDOH"
        ]
    }
}